DEF: US Antimony 2026 Proxy: Share Increase Proposal

Sentiment:

Proxy Statement


United States Antimony Corporation schedules its 2026 annual meeting to elect directors and vote on doubling authorized common shares.

Capital raiseThe company is seeking to increase authorized common stock from 250 million to 500 million shares to provide flexibility for future equity-based financings and strategic transactions.

Summary

  • The 2026 Annual Meeting of Shareholders is scheduled for June 12, 2026, at 4:15 P.M. ET, to be held virtually.
  • Shareholders will vote on the election of seven directors, an amendment to increase authorized common stock from 250 million to 500 million shares, and the ratification of Assure CPA, LLC as the independent auditor.
  • The company reported a net loss of $4,339,526 for the fiscal year ended December 31, 2025.
  • As of the April 15, 2026 record date, there were 143,078,275 shares of common stock outstanding.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral-to-cautious filing; while it is a standard proxy for annual business, the request for a massive increase in authorized shares combined with consistent net losses suggests a high likelihood of future dilution for shareholders.

Positives

  • The company has established a clear governance structure with standing Audit, Compensation, Finance, and Nominating and Corporate Governance committees.
  • The Board maintains a majority of independent directors (5 out of 7).
  • The company has implemented a Clawback Policy to recoup performance-based compensation in the event of financial restatements.

Negatives

  • The company reported a net loss of $4,339,526 for the 2025 fiscal year.
  • Several directors and executive officers filed required Section 16(a) ownership reports late in previous periods.
  • The company has no employment contracts or severance agreements with its named executive officers, which may impact retention stability.

Risks

  • The proposed increase in authorized shares could lead to significant dilution of existing shareholder equity.
  • The company may be constrained in its ability to raise capital or pursue strategic opportunities if the share increase is not approved.
  • The company faces risks associated with its reliance on the antimony industry and potential market volatility.
  • The company's financial performance has been negative, with losses reported in each of the last three fiscal years.

Future Outlook

The company intends to use the proposed increase in authorized shares to provide flexibility for future business opportunities, including potential equity-based financings, acquisitions, or strategic joint ventures, though no specific plans for such issuances currently exist.

Management Comments

  • The Board believes the proposed increase in authorized shares will benefit the company by improving flexibility in considering opportunities that require the issuance of shares.
  • The Board does not intend to issue any Common Stock except on terms which the Board deems to be in the best interests of the Company and its then existing shareholders.

Industry Context

StockSavvy.ai notes that the request to double authorized shares is a common defensive and strategic maneuver for small-cap mining companies to ensure liquidity for future capital raises or M&A, though it often signals potential future dilution to investors.

Comparison to Industry Standards

  • The company's governance structure, including the use of independent committees, aligns with standard practices for small-cap public companies.
  • The reliance on equity-based compensation for executives is consistent with industry norms for growth-stage or capital-intensive mining firms.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Committee EstablishmentThe Finance Committee was established in 2025.2025Enhances oversight of financial strategy and capital allocation.

Related Party Transactions

  • Effective March 1, 2026, the company hired Angel Beltran, the son-in-law of Chairman and CEO Gary C. Evans, to work in antimony operations and special projects.

Stakeholder Impact

  • Shareholders face potential dilution of voting power and equity interest if the authorized share increase is utilized.
  • Employees and consultants may receive equity-based compensation from the newly authorized share pool.

Next Steps

  • Hold the 2026 Annual Meeting of Shareholders on June 12, 2026.
  • Conduct shareholder vote on director elections, share authorization increase, and auditor ratification.
  • File Certificate of Amendment with the State of Texas if Proposal 2 is approved.

Key Dates

DateDescription
2026-04-15Record date for shareholders entitled to vote at the annual meeting.
2026-04-20Approximate date proxy materials are mailed to shareholders.
2026-05-29Deadline to request paper or email copies of proxy materials.
2026-06-11Deadline for internet and telephone voting by 11:59 p.m. ET.
2026-06-122026 Annual Meeting of Shareholders.

Recommendation

hold

The company is in a loss-making position and is seeking to double its authorized share count, which creates a significant overhang of potential dilution. Investors should hold until there is evidence of operational profitability or a clear, value-accretive use of the proposed share authorization.

Keywords

United States Antimony Corporation, UAMY, Proxy Statement, Shareholder Meeting, Capital Raise, Corporate Governance, Antimony

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.